ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.298 USD | -0.63% |
|
0.00% | 0.00% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 422.9 USD | -1.63% | +3.08% | +3.93% | 8.46% | ||
| 978.5 USD | +0.16% | +0.85% | +11.38% | 7.85% | ||
| 309.2 USD | +0.23% | +2.82% | +7.20% | 7.84% | ||
| 67.14 USD | -0.58% | +2.58% | -17.11% | 7.77% | ||
| 223.7 USD | -0.74% | +1.97% | -13.73% | 3.86% | ||
| 128.9 USD | +2.60% | +6.38% | +29.51% | 3.85% | ||
| 147.4 USD | -1.64% | -4.74% | -23.19% | 2.51% | ||
| 116.8 USD | +3.61% | +3.35% | -16.26% | 2.31% | ||
| 79.8 USD | -0.88% | -3.45% | -17.31% | 1.87% | ||
More news
In partnership with
| Date | Price | Change |
|---|---|---|
| 24-05-13 | - | -100.00% |
| 24-05-10 | 6.298 | -0.63% |
| 24-05-09 | 6.338 | -0.02% |
Other stock markets
Delayed Quote OTC Markets
Last update May 10, 2024 at 03:59 pm
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2017-10-17
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 421 M€ |
|---|---|
| AuM 1M | 432 M€ |
| AuM 3 months | 408 M€ |
| AuM 6 months | 329 M€ |
| AuM 12 months | 433 M€ |
- Stock Market
- ETF
- IVBUF ETF